Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001650757 | SCV001870867 | benign | not provided | 2019-10-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001650757 | SCV004154013 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | TRIO: BS2 |
Revvity Omics, |
RCV001650757 | SCV004236945 | uncertain significance | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004551961 | SCV004772782 | likely benign | TRIO-related disorder | 2019-07-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |